Global Recombinant Influenza Vaccine Supply, Demand and Key Producers, 2023-2029
The global Recombinant Influenza Vaccine market size is expected to reach $ 190 million by 2029, rising at a market growth of 8.1% CAGR during the forecast period (2023-2029).
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
Recombinant technology plays an important role in the preparation of influenza vaccines. It allows scientists to create and express specific influenza virus proteins through genetic engineering to prepare influenza vaccines. This approach typically involves inserting the genetic sequence of the influenza virus into an expression system, enabling it to produce viral antigen proteins, and then using these proteins to prepare a vaccine.
This report studies the global Recombinant Influenza Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Influenza Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Influenza Vaccine total production and demand, 2018-2029, (K Units)
Global Recombinant Influenza Vaccine total production value, 2018-2029, (USD Million)
Global Recombinant Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Recombinant Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Recombinant Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Influenza Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Influenza Vaccine Market, By Region:
1. How big is the global Recombinant Influenza Vaccine market?
2. What is the demand of the global Recombinant Influenza Vaccine market?
3. What is the year over year growth of the global Recombinant Influenza Vaccine market?
4. What is the production and production value of the global Recombinant Influenza Vaccine market?
5. Who are the key producers in the global Recombinant Influenza Vaccine market?
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
Recombinant technology plays an important role in the preparation of influenza vaccines. It allows scientists to create and express specific influenza virus proteins through genetic engineering to prepare influenza vaccines. This approach typically involves inserting the genetic sequence of the influenza virus into an expression system, enabling it to produce viral antigen proteins, and then using these proteins to prepare a vaccine.
This report studies the global Recombinant Influenza Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Influenza Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Influenza Vaccine total production and demand, 2018-2029, (K Units)
Global Recombinant Influenza Vaccine total production value, 2018-2029, (USD Million)
Global Recombinant Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Recombinant Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Recombinant Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Influenza Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Influenza Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Vial
- Prefilled
- Public Sector
- Private Sector
- Sanofi
1. How big is the global Recombinant Influenza Vaccine market?
2. What is the demand of the global Recombinant Influenza Vaccine market?
3. What is the year over year growth of the global Recombinant Influenza Vaccine market?
4. What is the production and production value of the global Recombinant Influenza Vaccine market?
5. Who are the key producers in the global Recombinant Influenza Vaccine market?
1 SUPPLY SUMMARY
1.1 Recombinant Influenza Vaccine Introduction
1.2 World Recombinant Influenza Vaccine Supply & Forecast
1.2.1 World Recombinant Influenza Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Influenza Vaccine Production (2018-2029)
1.2.3 World Recombinant Influenza Vaccine Pricing Trends (2018-2029)
1.3 World Recombinant Influenza Vaccine Production by Region (Based on Production Site)
1.3.1 World Recombinant Influenza Vaccine Production Value by Region (2018-2029)
1.3.2 World Recombinant Influenza Vaccine Production by Region (2018-2029)
1.3.3 World Recombinant Influenza Vaccine Average Price by Region (2018-2029)
1.3.4 North America Recombinant Influenza Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Influenza Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Influenza Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Recombinant Influenza Vaccine Demand (2018-2029)
2.2 World Recombinant Influenza Vaccine Consumption by Region
2.2.1 World Recombinant Influenza Vaccine Consumption by Region (2018-2023)
2.2.2 World Recombinant Influenza Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Influenza Vaccine Consumption (2018-2029)
2.4 China Recombinant Influenza Vaccine Consumption (2018-2029)
2.5 Europe Recombinant Influenza Vaccine Consumption (2018-2029)
2.6 Japan Recombinant Influenza Vaccine Consumption (2018-2029)
2.7 South Korea Recombinant Influenza Vaccine Consumption (2018-2029)
2.8 ASEAN Recombinant Influenza Vaccine Consumption (2018-2029)
2.9 India Recombinant Influenza Vaccine Consumption (2018-2029)
3 WORLD RECOMBINANT INFLUENZA VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Influenza Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Influenza Vaccine Production by Manufacturer (2018-2023)
3.3 World Recombinant Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Recombinant Influenza Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Influenza Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Influenza Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Influenza Vaccine in 2022
3.6 Recombinant Influenza Vaccine Market: Overall Company Footprint Analysis
3.6.1 Recombinant Influenza Vaccine Market: Region Footprint
3.6.2 Recombinant Influenza Vaccine Market: Company Product Type Footprint
3.6.3 Recombinant Influenza Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Influenza Vaccine Production Value Comparison
4.1.1 United States VS China: Recombinant Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Influenza Vaccine Production Comparison
4.2.1 United States VS China: Recombinant Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Influenza Vaccine Consumption Comparison
4.3.1 United States VS China: Recombinant Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Influenza Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023)
4.5 China Based Recombinant Influenza Vaccine Manufacturers and Market Share
4.5.1 China Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Influenza Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023)
4.6 Rest of World Based Recombinant Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Influenza Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vial
5.2.2 Prefilled
5.3 Market Segment by Type
5.3.1 World Recombinant Influenza Vaccine Production by Type (2018-2029)
5.3.2 World Recombinant Influenza Vaccine Production Value by Type (2018-2029)
5.3.3 World Recombinant Influenza Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Public Sector
6.2.2 Private Sector
6.3 Market Segment by Application
6.3.1 World Recombinant Influenza Vaccine Production by Application (2018-2029)
6.3.2 World Recombinant Influenza Vaccine Production Value by Application (2018-2029)
6.3.3 World Recombinant Influenza Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Recombinant Influenza Vaccine Product and Services
7.1.4 Sanofi Recombinant Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant Influenza Vaccine Industry Chain
8.2 Recombinant Influenza Vaccine Upstream Analysis
8.2.1 Recombinant Influenza Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Influenza Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Influenza Vaccine Production Mode
8.6 Recombinant Influenza Vaccine Procurement Model
8.7 Recombinant Influenza Vaccine Industry Sales Model and Sales Channels
8.7.1 Recombinant Influenza Vaccine Sales Model
8.7.2 Recombinant Influenza Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Recombinant Influenza Vaccine Introduction
1.2 World Recombinant Influenza Vaccine Supply & Forecast
1.2.1 World Recombinant Influenza Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Influenza Vaccine Production (2018-2029)
1.2.3 World Recombinant Influenza Vaccine Pricing Trends (2018-2029)
1.3 World Recombinant Influenza Vaccine Production by Region (Based on Production Site)
1.3.1 World Recombinant Influenza Vaccine Production Value by Region (2018-2029)
1.3.2 World Recombinant Influenza Vaccine Production by Region (2018-2029)
1.3.3 World Recombinant Influenza Vaccine Average Price by Region (2018-2029)
1.3.4 North America Recombinant Influenza Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Influenza Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Influenza Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Recombinant Influenza Vaccine Demand (2018-2029)
2.2 World Recombinant Influenza Vaccine Consumption by Region
2.2.1 World Recombinant Influenza Vaccine Consumption by Region (2018-2023)
2.2.2 World Recombinant Influenza Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Influenza Vaccine Consumption (2018-2029)
2.4 China Recombinant Influenza Vaccine Consumption (2018-2029)
2.5 Europe Recombinant Influenza Vaccine Consumption (2018-2029)
2.6 Japan Recombinant Influenza Vaccine Consumption (2018-2029)
2.7 South Korea Recombinant Influenza Vaccine Consumption (2018-2029)
2.8 ASEAN Recombinant Influenza Vaccine Consumption (2018-2029)
2.9 India Recombinant Influenza Vaccine Consumption (2018-2029)
3 WORLD RECOMBINANT INFLUENZA VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Influenza Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Influenza Vaccine Production by Manufacturer (2018-2023)
3.3 World Recombinant Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Recombinant Influenza Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Influenza Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Influenza Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Influenza Vaccine in 2022
3.6 Recombinant Influenza Vaccine Market: Overall Company Footprint Analysis
3.6.1 Recombinant Influenza Vaccine Market: Region Footprint
3.6.2 Recombinant Influenza Vaccine Market: Company Product Type Footprint
3.6.3 Recombinant Influenza Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Influenza Vaccine Production Value Comparison
4.1.1 United States VS China: Recombinant Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Influenza Vaccine Production Comparison
4.2.1 United States VS China: Recombinant Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Influenza Vaccine Consumption Comparison
4.3.1 United States VS China: Recombinant Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Influenza Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023)
4.5 China Based Recombinant Influenza Vaccine Manufacturers and Market Share
4.5.1 China Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Influenza Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023)
4.6 Rest of World Based Recombinant Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Influenza Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vial
5.2.2 Prefilled
5.3 Market Segment by Type
5.3.1 World Recombinant Influenza Vaccine Production by Type (2018-2029)
5.3.2 World Recombinant Influenza Vaccine Production Value by Type (2018-2029)
5.3.3 World Recombinant Influenza Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Public Sector
6.2.2 Private Sector
6.3 Market Segment by Application
6.3.1 World Recombinant Influenza Vaccine Production by Application (2018-2029)
6.3.2 World Recombinant Influenza Vaccine Production Value by Application (2018-2029)
6.3.3 World Recombinant Influenza Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Recombinant Influenza Vaccine Product and Services
7.1.4 Sanofi Recombinant Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant Influenza Vaccine Industry Chain
8.2 Recombinant Influenza Vaccine Upstream Analysis
8.2.1 Recombinant Influenza Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Influenza Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Influenza Vaccine Production Mode
8.6 Recombinant Influenza Vaccine Procurement Model
8.7 Recombinant Influenza Vaccine Industry Sales Model and Sales Channels
8.7.1 Recombinant Influenza Vaccine Sales Model
8.7.2 Recombinant Influenza Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Recombinant Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Influenza Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Influenza Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Influenza Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Influenza Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Influenza Vaccine Production Market Share by Region (2018-2023)
Table 9. World Recombinant Influenza Vaccine Production Market Share by Region (2024-2029)
Table 10. World Recombinant Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Influenza Vaccine Major Market Trends
Table 13. World Recombinant Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Influenza Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Influenza Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Influenza Vaccine Producers in 2022
Table 18. World Recombinant Influenza Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Influenza Vaccine Producers in 2022
Table 20. World Recombinant Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Influenza Vaccine Company Evaluation Quadrant
Table 22. World Recombinant Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Influenza Vaccine Production Site of Key Manufacturer
Table 24. Recombinant Influenza Vaccine Market: Company Product Type Footprint
Table 25. Recombinant Influenza Vaccine Market: Company Product Application Footprint
Table 26. Recombinant Influenza Vaccine Competitive Factors
Table 27. Recombinant Influenza Vaccine New Entrant and Capacity Expansion Plans
Table 28. Recombinant Influenza Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Influenza Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Influenza Vaccine Production Market Share (2018-2023)
Table 37. China Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Influenza Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Influenza Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Influenza Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Influenza Vaccine Production Market Share (2018-2023)
Table 47. World Recombinant Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Influenza Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Influenza Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Influenza Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Influenza Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Recombinant Influenza Vaccine Product and Services
Table 64. Sanofi Recombinant Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Global Key Players of Recombinant Influenza Vaccine Upstream (Raw Materials)
Table 66. Recombinant Influenza Vaccine Typical Customers
Table 67. Recombinant Influenza Vaccine Typical Distributors
List of Figure
Figure 1. Recombinant Influenza Vaccine Picture
Figure 2. World Recombinant Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Influenza Vaccine Production (2018-2029) & (K Units)
Figure 5. World Recombinant Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Influenza Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Influenza Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Influenza Vaccine Production (2018-2029) & (K Units)
Figure 9. Recombinant Influenza Vaccine Market Drivers
Figure 10. Factors Affecting Demand
Figure 11. World Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 12. World Recombinant Influenza Vaccine Consumption Market Share by Region (2018-2029)
Figure 13. United States Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 14. China Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 15. Europe Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 16. Japan Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 17. South Korea Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 18. ASEAN Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 19. India Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 20. Producer Shipments of Recombinant Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 21. Global Four-firm Concentration Ratios (CR4) for Recombinant Influenza Vaccine Markets in 2022
Figure 22. Global Four-firm Concentration Ratios (CR8) for Recombinant Influenza Vaccine Markets in 2022
Figure 23. United States VS China: Recombinant Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 24. United States VS China: Recombinant Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 25. United States VS China: Recombinant Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 26. United States Based Manufacturers Recombinant Influenza Vaccine Production Market Share 2022
Figure 27. China Based Manufacturers Recombinant Influenza Vaccine Production Market Share 2022
Figure 28. Rest of World Based Manufacturers Recombinant Influenza Vaccine Production Market Share 2022
Figure 29. World Recombinant Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Recombinant Influenza Vaccine Production Value Market Share by Type in 2022
Figure 31. Vial
Figure 32. Prefilled
Figure 33. World Recombinant Influenza Vaccine Production Market Share by Type (2018-2029)
Figure 34. World Recombinant Influenza Vaccine Production Value Market Share by Type (2018-2029)
Figure 35. World Recombinant Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 36. World Recombinant Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Recombinant Influenza Vaccine Production Value Market Share by Application in 2022
Figure 38. Public Sector
Figure 39. Private Sector
Figure 40. World Recombinant Influenza Vaccine Production Market Share by Application (2018-2029)
Figure 41. World Recombinant Influenza Vaccine Production Value Market Share by Application (2018-2029)
Figure 42. World Recombinant Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 43. Recombinant Influenza Vaccine Industry Chain
Figure 44. Recombinant Influenza Vaccine Procurement Model
Figure 45. Recombinant Influenza Vaccine Sales Model
Figure 46. Recombinant Influenza Vaccine Sales Channels, Direct Sales, and Distribution
Figure 47. Methodology
Figure 48. Research Process and Data Source
Table 1. World Recombinant Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Influenza Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Influenza Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Influenza Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Influenza Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Influenza Vaccine Production Market Share by Region (2018-2023)
Table 9. World Recombinant Influenza Vaccine Production Market Share by Region (2024-2029)
Table 10. World Recombinant Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Influenza Vaccine Major Market Trends
Table 13. World Recombinant Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Influenza Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Influenza Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Influenza Vaccine Producers in 2022
Table 18. World Recombinant Influenza Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Influenza Vaccine Producers in 2022
Table 20. World Recombinant Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Influenza Vaccine Company Evaluation Quadrant
Table 22. World Recombinant Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Influenza Vaccine Production Site of Key Manufacturer
Table 24. Recombinant Influenza Vaccine Market: Company Product Type Footprint
Table 25. Recombinant Influenza Vaccine Market: Company Product Application Footprint
Table 26. Recombinant Influenza Vaccine Competitive Factors
Table 27. Recombinant Influenza Vaccine New Entrant and Capacity Expansion Plans
Table 28. Recombinant Influenza Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Influenza Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Influenza Vaccine Production Market Share (2018-2023)
Table 37. China Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Influenza Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Influenza Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Influenza Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Influenza Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Influenza Vaccine Production Market Share (2018-2023)
Table 47. World Recombinant Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Influenza Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Influenza Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Influenza Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Influenza Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Recombinant Influenza Vaccine Product and Services
Table 64. Sanofi Recombinant Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Global Key Players of Recombinant Influenza Vaccine Upstream (Raw Materials)
Table 66. Recombinant Influenza Vaccine Typical Customers
Table 67. Recombinant Influenza Vaccine Typical Distributors
List of Figure
Figure 1. Recombinant Influenza Vaccine Picture
Figure 2. World Recombinant Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Influenza Vaccine Production (2018-2029) & (K Units)
Figure 5. World Recombinant Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Influenza Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Influenza Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Influenza Vaccine Production (2018-2029) & (K Units)
Figure 9. Recombinant Influenza Vaccine Market Drivers
Figure 10. Factors Affecting Demand
Figure 11. World Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 12. World Recombinant Influenza Vaccine Consumption Market Share by Region (2018-2029)
Figure 13. United States Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 14. China Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 15. Europe Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 16. Japan Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 17. South Korea Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 18. ASEAN Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 19. India Recombinant Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 20. Producer Shipments of Recombinant Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 21. Global Four-firm Concentration Ratios (CR4) for Recombinant Influenza Vaccine Markets in 2022
Figure 22. Global Four-firm Concentration Ratios (CR8) for Recombinant Influenza Vaccine Markets in 2022
Figure 23. United States VS China: Recombinant Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 24. United States VS China: Recombinant Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 25. United States VS China: Recombinant Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 26. United States Based Manufacturers Recombinant Influenza Vaccine Production Market Share 2022
Figure 27. China Based Manufacturers Recombinant Influenza Vaccine Production Market Share 2022
Figure 28. Rest of World Based Manufacturers Recombinant Influenza Vaccine Production Market Share 2022
Figure 29. World Recombinant Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Recombinant Influenza Vaccine Production Value Market Share by Type in 2022
Figure 31. Vial
Figure 32. Prefilled
Figure 33. World Recombinant Influenza Vaccine Production Market Share by Type (2018-2029)
Figure 34. World Recombinant Influenza Vaccine Production Value Market Share by Type (2018-2029)
Figure 35. World Recombinant Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 36. World Recombinant Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Recombinant Influenza Vaccine Production Value Market Share by Application in 2022
Figure 38. Public Sector
Figure 39. Private Sector
Figure 40. World Recombinant Influenza Vaccine Production Market Share by Application (2018-2029)
Figure 41. World Recombinant Influenza Vaccine Production Value Market Share by Application (2018-2029)
Figure 42. World Recombinant Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 43. Recombinant Influenza Vaccine Industry Chain
Figure 44. Recombinant Influenza Vaccine Procurement Model
Figure 45. Recombinant Influenza Vaccine Sales Model
Figure 46. Recombinant Influenza Vaccine Sales Channels, Direct Sales, and Distribution
Figure 47. Methodology
Figure 48. Research Process and Data Source
